476 related articles for article (PubMed ID: 8052379)
1. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
Smith MV; Laws ER
Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
[TBL] [Abstract][Full Text] [Related]
2. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
Nyquist P; Laws ER; Elliott E
Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
4. Transsphenoidal surgery for pituitary adenomas in children.
Dyer EH; Civit T; Visot A; Delalande O; Derome P
Neurosurgery; 1994 Feb; 34(2):207-12; discussion 212. PubMed ID: 8177379
[TBL] [Abstract][Full Text] [Related]
5. The hook effect in prolactin immunoassays.
Al Sifri SN; Raef H
Saudi Med J; 2004 May; 25(5):656-9. PubMed ID: 15138537
[TBL] [Abstract][Full Text] [Related]
6. MRI of pituitary adenomas in acromegaly.
Marro B; Zouaoui A; Sahel M; Crozat N; Gerber S; Sourour N; Sag K; Marsault C
Neuroradiology; 1997 Jun; 39(6):394-9. PubMed ID: 9225316
[TBL] [Abstract][Full Text] [Related]
7. A clinical and histopathological study of factors affecting MRI signal intensities of pituitary adenomas.
Kobayashi S; Ikeda H; Yoshimoto T
Neuroradiology; 1994 May; 36(4):298-302. PubMed ID: 8065575
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinaemia in patients with pituitary adenomas. The pituitary stalk compression syndrome.
Kruse A; Astrup J; Gyldensted C; Cold GE
Br J Neurosurg; 1995; 9(4):453-7. PubMed ID: 7576271
[TBL] [Abstract][Full Text] [Related]
9. [Prolactin producing adenoma].
Tamaki N; Yonezawa K
Nihon Rinsho; 1993 Oct; 51(10):2685-90. PubMed ID: 8254940
[TBL] [Abstract][Full Text] [Related]
10. MRI--diagnostic and follow-up tool for microprolactinomas.
Seidl Z; Obenberger J; Marek J; Hána V; Vanĕcková M
Funct Neurol; 2000; 15(1):47-51. PubMed ID: 10842760
[TBL] [Abstract][Full Text] [Related]
11. Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma. Case report.
Albuquerque FC; Hinton DR; Weiss MH
J Neurosurg; 1998 Dec; 89(6):1043-6. PubMed ID: 9833836
[TBL] [Abstract][Full Text] [Related]
12. Masked hyperprolactinemia: tumor-derived factors inhibiting prolactin secretion caused by pituitary-stalk damage.
Kinoshita Y; Hama S; Tominaga A; Arita K; Sugiyama K; Sakoguchi T; Usui S; Kurisu K
J Clin Neurosci; 2011 Dec; 18(12):1651-5. PubMed ID: 22015098
[TBL] [Abstract][Full Text] [Related]
13. Pituitary enlargement with suprasellar extension in functional hyperprolactinemia due to lactotroph hyperplasia: a pseudotumoral disease.
Peillon F; Dupuy M; Li JY; Kujas M; Vincens M; Mowszowicz I; Derome P
J Clin Endocrinol Metab; 1991 Nov; 73(5):1008-15. PubMed ID: 1939514
[TBL] [Abstract][Full Text] [Related]
14. Selective excision of adenomas originating in or extending into the pituitary stalk with preservation of pituitary function.
Mason RB; Nieman LK; Doppman JL; Oldfield EH
J Neurosurg; 1997 Sep; 87(3):343-51. PubMed ID: 9285597
[TBL] [Abstract][Full Text] [Related]
15. Ectopic pituitary adenoma located at the pituitary stalk. Case report.
Peker S; Sun I; Kurtkaya-Yapicier O; Elmaci I; Pamir MN
J Neurosurg Sci; 2005 Mar; 49(1):25-9. PubMed ID: 15990716
[TBL] [Abstract][Full Text] [Related]
16. [MRI: incidence and evaluation of size and form criteria in hypophysis-healthy probands and in patients with detectable microadenomas].
Dietrich CF; Kirchner J; Higer P; Heyd R; Berkefeld J
Aktuelle Radiol; 1997 May; 7(3):130-4. PubMed ID: 9296607
[TBL] [Abstract][Full Text] [Related]
17. Falsely low serum prolactin in two cases of invasive macroprolactinoma.
Schöfl C; Schöfl-Siegert B; Karstens JH; Bremer M; Lenarz T; Cuarezma JS; Samii M; von zur Mühlen A; Brabant G
Pituitary; 2002; 5(4):261-5. PubMed ID: 14558675
[TBL] [Abstract][Full Text] [Related]
18. A predictive algorithm for evaluating elevated serum prolactin in patients with a sellar mass.
Cheng JS; Salinas R; Molinaro A; Chang EF; Kunwar S; Blevins L; Aghi MK
J Clin Neurosci; 2015 Jan; 22(1):155-60. PubMed ID: 25481269
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
[TBL] [Abstract][Full Text] [Related]
20. Is a stable or decreasing prolactin level in a patient with prolactinoma a surrogate marker for lack of tumor growth?
Alkabbani AG; Mon SY; Hatipoglu B; Kennedy L; Faiman C; Weil RJ; Hamrahian AH
Pituitary; 2014 Apr; 17(2):97-102. PubMed ID: 23468127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
